公开(公告)号：US20230293024A1

公开(公告)日：2023-09-21

申请号：US18163175

申请日：2023-02-01

Applicant: Medtronic, Inc.

Inventor： Elise J. Higgins ,  Yong K. Cho ,  Richard J. O’Brien ,  David J. Miller ,  Rhea M. May ,  Cynthia C. Barber ,  Randal C. Schulhauser ,  Sarah J. Yoon ,  Heather I. Tuccolo

IPC: A61B5/0205 ,  A61B5/1455 ,  A61B5/389 ,  A61B5/145 ,  A61B5/00 ,  A61B5/0537 ,  A61B5/28 ,  A61B5/296 ,  A61B10/00

CPC classification number: A61B5/02055 ,  A61B5/0537 ,  A61B5/14532 ,  A61B5/14551 ,  A61B5/28 ,  A61B5/296 ,  A61B5/389 ,  A61B5/4227 ,  A61B5/4356 ,  A61B5/7475 ,  A61B10/0012 ,  A61B5/0245

Abstract: A system for sensing one or more physiological traits and obstetric conditions, such as a fertility phase, pregnancy, labor, post-partum conditions, and other conditions related to the reproductive system of the patient. The system may use the one or more physiological traits sensed to define one or more patient attributes for the patient, such as a hormone level, heart rate, blood pressure, respiration rate, temperature, oxygen saturation level, uterine contractions, fluid level, and/or other patient attributes. The system is configured to compare the one or more patient attributes to one or more attribute signs describing a threshold for the one or more patient attributes. The system is configured to issue a communication to the patient and/or a clinician based on the comparisons. The system may be configured to assess and indicate reproductive phases for the patient over a life-cycle from the fertility phase to the post-partum phase.

公开(公告)号：US12201832B2

公开(公告)日：2025-01-21

申请号：US17656586

申请日：2022-03-25

Applicant: Medtronic, Inc.

Inventor： Leonid M. Litvak ,  Avram Scheiner ,  Kristin N. Hageman ,  Kanthaiah Koka ,  James Britton Hissong ,  Erik J. Peterson ,  David J. Miller ,  Robert T. Sandgren ,  Adam J. Rivard ,  Sean P. Skubitz ,  Thomas I. Miller

IPC: A61N1/36 ,  A61N1/05 ,  A61N1/372

Abstract: A medical system for obstructive sleep apnea (OSA) treatment includes therapy delivery circuitry configured to output one or more electrical stimulation signals to a tongue of a patient; sensing circuitry configured to sense one or more compound muscle action potential (CMAP) signals, wherein the one or more CMAP signals are generated in response to the delivery of the one or more electrical stimulation signals; and processing circuitry configured to: cause the therapy delivery circuitry to output the one or more electrical stimulation signals to the tongue; receive information indicative of the one or more CMAP signals from the sensing circuitry; determine, based on the one or more CMAP signals, one or more therapeutic stimulation parameters for the OSA treatment; and cause the therapy delivery circuitry to deliver therapeutic electrical stimulation signals according to at least the determined one or more therapeutic stimulation parameters.

公开(公告)号：US20230026849A1

公开(公告)日：2023-01-26

申请号：US17812356

申请日：2022-07-13

Applicant: Medtronic, Inc.

Inventor： David J. Miller

IPC: A61N1/05 ,  A61N1/02 ,  A61N1/36

Abstract: Example devices and techniques are disclosed for delivering neurostimulation therapy transesophageally. An example device includes stimulation circuitry configured to generate a transesophageal stimulation signal. The example device includes memory configured to store stimulation parameters that at least partially define the transesophageal stimulation signal and processing circuitry communicatively coupled to the memory, and the stimulation circuitry. The processing circuitry is configured to determine a maximum transesophageal stimulation amplitude value. The processing circuitry is configured to control the stimulation circuitry to generate the transesophageal stimulation signal based at least in part on at least one of the stimulation parameters or the maximum transesophageal stimulation amplitude such that an amplitude of the transesophageal stimulation signal does not exceed the maximum transesophageal stimulation amplitude.

公开(公告)号：US20240399154A1

公开(公告)日：2024-12-05

申请号：US18688210

申请日：2022-09-08

Applicant: Medtronic, Inc

Inventor： Benjamin Kevin Hendrick ,  Steven M. Goetz ,  David A. Simon ,  Maneesh Shrivastav ,  Leslie Hiemenz Holton ,  Xuan K. Wei ,  David J. Miller ,  Ryan B. Sefkow ,  Phillip C. Falkner ,  Meredith S. Seaborn ,  Richard T. Stone ,  Robert L. Olson ,  Scott D DeFoe

IPC: A61N1/36 ,  A61N1/05 ,  A61N1/372 ,  A61N1/378 ,  A61N2/00 ,  A61N2/02

Abstract: Devices, systems, and techniques are disclosed for planning, updating, and delivering electric field therapy. In one example, a system comprises processing circuitry configured to receive a request to deliver alternating electric field (AEF) therapy and determine therapy parameter values that define the AEF therapy, wherein the AEF therapy comprises delivery of a first electric field and a second electric field. The processing circuitry may also be configured to control an implantable medical device to deliver the first electric field from a first electrode combination of implanted electrodes and control the implantable medical device to deliver, alternating with the first electric field, the second electric field from a second electrode combination of implanted electrodes different than the first electrode combination.

公开(公告)号：US20240139516A1

公开(公告)日：2024-05-02

申请号：US18050872

申请日：2022-10-28

Applicant: Medtronic, Inc.

Inventor： James Britton Hissong ,  Robert T. Sandgren ,  Erik J. Peterson ,  Sean P. Skubitz ,  Adam J. Rivard ,  Thomas I. Miller ,  David J. Miller ,  Kristin N. Hageman ,  Avram Scheiner ,  Kanthaiah Koka ,  Leonid M. Litvak

IPC: A61N1/36 ,  A61N1/02

CPC classification number: A61N1/36139 ,  A61N1/025 ,  A61N1/3606

Abstract: A system includes memory, and processing circuitry coupled to the memory, the processing circuitry configured to: determine at least one of: a cross-electrical signal measurement at a first electrode on a first lead implanted within a tongue of the patient based on a stimulation signal between a second electrode on the first lead or a second lead implanted within the tongue of the patient and a third electrode, or a strain measurement of at least one of the first lead or the second lead. The processing circuitry is configured to determine movement of the tongue based on at least one of the cross-electrical signal measurement or the strain measurement, and generate information indicative of the movement of the tongue.

公开(公告)号：US20230302276A1

公开(公告)日：2023-09-28

申请号：US17656586

申请日：2022-03-25

Applicant: Medtronic, Inc.

Inventor： Leonid M. Litvak ,  Avram Scheiner ,  Kristin N. Hageman ,  Kanthaiah Koka ,  James Britton Hissong ,  Erik J. Peterson ,  David J. Miller ,  Robert T. Sandgren ,  Adam J. Rivard ,  Sean P. Skubitz ,  Thomas I. Miller

IPC: A61N1/36 ,  A61N1/05 ,  A61N1/372

CPC classification number: A61N1/36003 ,  A61N1/0548 ,  A61N1/37235 ,  A61N1/36139

Abstract: A medical system for obstructive sleep apnea (OSA) treatment includes therapy delivery circuitry configured to output one or more electrical stimulation signals to a tongue of a patient; sensing circuitry configured to sense one or more compound muscle action potential (CMAP) signals, wherein the one or more CMAP signals are generated in response to the delivery of the one or more electrical stimulation signals; and processing circuitry configured to: cause the therapy delivery circuitry to output the one or more electrical stimulation signals to the tongue; receive information indicative of the one or more CMAP signals from the sensing circuitry; determine, based on the one or more CMAP signals, one or more therapeutic stimulation parameters for the OSA treatment; and cause the therapy delivery circuitry to deliver therapeutic electrical stimulation signals according to at least the determined one or more therapeutic stimulation parameters.